Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
NPC L NPC Niemann Pick C like like
2020-08-10

NPC1L1 (NPC1 [Niemann-Pick C-like-1]-like intracellular cholesterol transporter) is the rate-limiting transmembrane transporter for cholesterol alkylation of dna from the intestinal lumen, and it mediates the absorption of both dietary and biliary cholesterol., , NPC1L1 is the target of the choles
-
br Materials and methods br Results br Discussion COX mediat
2020-08-10

Materials and methods Results Discussion COX-2-mediated production of PGE2 is involved in cell growth and metastasis of many cancers. Previous studies indicated that COX-2 was overexpressed in many cancer tissues and that PGE2 increased cancer cell growth, a process that could be suppressed
-
br Conflict of interest statement br References and recommen
2020-08-10

Conflict of interest statement References and recommended reading Papers of particular interest, published within the period of review, have been highlighted as: Acknowledgements We acknowledge financial support by the Swiss State Secretariat for Education, Research and Innovation (Federal
-
In conclusion we designed novel
2020-08-10

In conclusion, we designed novel E1 inhibitors based on the three-dimensional structure of E1 in complex with ubiquitin. Following an enzymatic assay evaluating synthetic compounds , , and , we identified compound as a novel E1 inhibitor. Comparing the inhibitory activity of compound with and ,
-
Initially we ascertained that if the dose of
2020-08-10

Initially, we ascertained that if the dose of elastase was sufficient to cause pulmonary emphysema, then pulmonary emphysema could be maintained throughout the study. We found that elastase at 3U was sufficient to cause emphysema that remained over 35 days. In this experimental design of lung diseas
-
azd6244 Contrary to the downregulation of
2020-08-10

Contrary to the downregulation of S1PR family GPCRs, CLL cells have increased mRNA expression of the lysophosphatidic azd6244 (LPA) family receptors LPAR1, LPAR3 and LPAR4 compared to normal B cells [47]. Increased LPAR1 mRNA has been shown to be associated with more aggressive disease [47] and LPA
-
Our data furthermore suggest that Ch h induced oxysterols
2020-08-10

Our data furthermore suggest that Ch25h-induced oxysterols could play an important role in modulating the immune cell migration. Mechanistically, we observed impaired trafficking of CD44+CD4+ T cells in mice deficient for Ch25h. CD44+CD4+ T cells lacking EBI2, the receptor of 7α-25OHC, were delayed
-
br Results and discussion br Conclusion
2020-08-08

Results and discussion Conclusion Novel and selective aziridine-based inhibitors for the Leishmania mexicana protease LmCBP2.8 were discovered. Compounds 7d (Ki = 0.8 μM), 9d (Ki = 1.36 μM), 12d (Ki = 0.77 μM), 14d (Ki = 0.9 μM) and 18 (Ki = 0.441 μM) showed the highest potency and selectivity
-
Our data suggest that VEGF
2020-08-08

Our data suggest that VEGF-A inhibits venous identity in adult EC, recapitulating the change seen during vein graft 2602 in vivo. Vein graft adaptation to the arterial environment may depend on the plasticity of adult EC, and their ability to integrate VEGF signaling pathways, to properly modify th
-
br Disclosure br Competing interest br Funding This work
2020-08-07

Disclosure Competing interest Funding This work was supported by a grant from the Austrian Science Foundation (FWF project P27383) to W.K. Work in the E.G. lab was supported by DLR grant 50WB1166. S.B. lab was supported by the Austrian Science Foundation FWF (grant P27183-B24) and the Swedi
-
We found that Th cells derived
2020-08-07

We found that Th17 cells, derived either from in vivo immunization or in vitro polarization under pathogenic conditions (in presence of IL-23 and/or IL-1β) expressed high levels of EBI2. In contrast, Th17 Almorexant sale that were generated in absence of IL-23 or IL-1β lost EBI2 expression during d
-
839 The combination of brequinar and fluorouracil
2020-08-07

The combination of brequinar and 5-fluorouracil (5-FU) has been evaluated to assess whether brequinar-induced uridine depletion would improve 5-FU activity. In cells, 5-FU is metabolized into FdUMP and inhibits thymidylate synthetase, which catalyzes the formation of thymidine monophosphate from deo
-
droperidol br Materials and methods br Results br Discussion
2020-08-06

Materials and methods Results Discussion In the present study, we have assessed which ER was involved in the protective effects of tibolone on astrocytic cells treated with PA. Then, we evaluated whether tibolone may modulate the expression of genes related to inflammation, astrocytic marke
-
br Results and discussion The test compounds listed
2020-08-06

Results and discussion The test compounds listed in Table 1, Table 2 were biologically evaluated for inhibition of the specific binding of a radiolabeled ligand [3H]PGE2 to membrane fractions prepared from nisoldipine stably expressing each mouse prostanoid receptor. The EP1 antagonist propertie
-
Six substrate recognition sites SRS SRS
2020-08-06

Six substrate recognition sites (SRS1-SRS6) have been identified at positions 102-123, 204-209, 238-244, 301-319, 374-382 and 483-492 (Table 2, underlined residues) based on Gotoh\'s proposal [30]. CYP3A163 displays the similar characteristic long sequences between helices F and G presenting two add
16279 records 834/1086 page Previous Next First page 上5页 831832833834835 下5页 Last page